3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2(5h)-furanone and Heart Failure

3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2(5h)-furanone has been researched along with Heart Failure in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aleksic, N; Delgado, RM; Kar, B; Mann, DL; McKay, K; Nawar, MA; Sivasubramanian, N; Vaughn, WK; Willerson, JT; Wu, KK; Zewail, AM	1

Other Studies

1 other study(ies) available for 3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2(5h)-furanone and Heart Failure

Article	Year
Cyclooxygenase-2 inhibitor treatment improves left ventricular function and mortality in a murine model of doxorubicin-induced heart failure. Circulation, 2004, Mar-23, Volume: 109, Issue:11 Topics: Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Progression; Doxorubicin; Drug Evaluation, Preclinical; Furans; Heart Failure; Inflammation Mediators; Isoenzymes; Mice; Prostaglandin-Endoperoxide Synthases; Reproducibility of Results; Single-Blind Method; Ultrasonography; Ventricular Dysfunction, Left; Ventricular Function, Left	2004

Article

Year

Cyclooxygenase-2 inhibitor treatment improves left ventricular function and mortality in a murine model of doxorubicin-induced heart failure.

Circulation, 2004, Mar-23, Volume: 109, Issue:11

Topics: Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Progression; Doxorubicin; Drug Evaluation, Preclinical; Furans; Heart Failure; Inflammation Mediators; Isoenzymes; Mice; Prostaglandin-Endoperoxide Synthases; Reproducibility of Results; Single-Blind Method; Ultrasonography; Ventricular Dysfunction, Left; Ventricular Function, Left

2004